AIVEX | REREX | AIVEX / REREX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 5 years | 23 years | - |
Gain YTD | 7.631 | 6.653 | 115% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 250 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.1B | 131B | 2% |
Annual Yield % from dividends | 1.09 | 1.54 | 71% |
Returns for 1 year | 5.55 | 1.50 | 370% |
Returns for 3 years | 15.17 | 1.66 | 912% |
Returns for 5 years | 25.82 | 7.95 | 325% |
Returns for 10 years | N/A | 20.33 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ETNHX | 34.51 | -0.36 | -1.03% |
Eventide Healthcare & Life Sciences N | |||
HFLGX | 11.34 | -0.16 | -1.39% |
Hennessy Cornerstone Large Growth Inv | |||
GSVRX | 15.56 | -0.23 | -1.46% |
Goldman Sachs Large Cap Value R | |||
OLVCX | 19.51 | -0.42 | -2.11% |
JPMorgan Large Cap Value C | |||
SGPIX | 107.93 | -3.63 | -3.25% |
ProFunds Small Cap Growth Inv |